Results 251 to 260 of about 144,610 (311)

The Prognostic Value of EDRIC and Its Association With Radiation‐Induced Lymphopenia in Patients With Esophageal Cancer Undergoing Radical Radiotherapy: A Single‐Center Chinese Study

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study aimed to evaluate the predictive value of the estimated dose of radiation to immune cells (EDRIC) in patients with esophageal cancer receiving radical radiotherapy. We retrospectively reviewed the data of patients with esophageal cancer who underwent definitive radiotherapy at our institution.
Yue Ke, Chen Yang, Yu‐Xing Li, Xiao‐Xiao Liu, Xiao Liu, Jia‐Min Gao, Hong‐Bing Ma   +6 more
wiley   +1 more source

Heterogeneity Analyzed by CT‐Based Habitat Analysis for Clinical Management of Cancers: A Narrative Review

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Tumors are highly heterogeneous, and whole‐lesion radiomics analysis is a popular method for extracting texture features that reflect this heterogeneity, which can be used to build models for cancer diagnosis, staging, therapy response evaluation, and prognosis prediction.
Yang Zhang, Zhi‐Yan Jin, Min‐Ying Lydia Su   +2 more
wiley   +1 more source

Analysis of complete and incomplete response to neoadjuvant therapy in rectum cancer patients. [PDF]

Gastroenterol Hepatol Bed Bench
TajikRostami F, Tavirani MR, Ataei E, Rezaei-Tavirani M, Mohaghegh-Shalmani H, Norouzinia M.   +5 more
europepmc   +1 more source

Thyroid Cartilage Reconstruction With Titanium Mesh in Advanced Papillary Thyroid Carcinoma

The Laryngoscope, EarlyView.
We report the first case of titanium mesh reconstruction of the thyroid cartilage following resection of papillary thyroid carcinoma with preservation of the laryngeal mucosa. This technique provided excellent functional outcomes while maintaining oncologic resection in a patient with locally advanced disease.
Anna Christina Clements, Cassie Pan, Neel K. Bhatt, Mara Roth, Brittany Barber, Emily Marchiano   +5 more
wiley   +1 more source

Case Report: Atypical pattern of pathologic response in cutaneous transdifferentiated melanoma with rhabdomyoblastic differentiation following neoadjuvant therapy. [PDF]

Front Oncol
Paulino Serur I, Mendes Awni Cidale B, Leal Pereira AZ, Benfatti Olivato G, Kodja Zanetta G, Lissae Fugimori M, Gomes Cardim Mendes de Oliveira CR, Fernanda Hunziker M, Ribeiro Teixeira Júnior FJ, Ramella Munhoz R.   +9 more
europepmc   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

Mass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik, Petr Lapcik, Pavla Bouchalova, Pavel Bouchal   +3 more
wiley   +1 more source

Neoadjuvant Therapy in Resectable Advanced Melanoma: Swiss Real-World Data. [PDF]

Cancers (Basel)
Blumenröther AK, Fang Y, El Saadany T, Ramelyte E, Hasan Ali O, Kündig T, Mihic-Probst D, Steiner S, Maurer A, Dummer R, Mangana J, Maul LV.   +11 more
europepmc   +1 more source

KMT5C‐Mediated H4K20me3 Recruits EWSR1 to Propel Clear Cell Renal Cell Carcinoma Progression via Regulating ACADM Transcription and m6A Modification

Med Research, EarlyView.
A schematic diagram illustrating the KMT5C‐H4K20me3‐EWSR1‐ACADM signaling axis and its role in ccRCC progression. Key Outcomes: KMT5C/H4K20me3 are upregulated in ccRCC and predict poor prognosis. EWSR1 is a novel noncanonical H4K20me3 reader in ccRCC. KMT5C/EWSR1 co‐repress ACADM via transcription and m6A modification. A‐196 + sunitinib synergistically
Chengjian Ji, Da Zhong, Tian Rao, Xiaojun Li, Weiyu Kong, Xi Zhang, Xiyi Wei, Bing Yao, Xinqiang Li, Ninghong Song, Chao Qin   +10 more
wiley   +1 more source

MYC amplification is common in cancer of the stomach and gastroesophageal junction, correlates with male sex and reduced response to neoadjuvant therapy. [PDF]

BMC Cancer
Biegler O, Behrens HM, Haag J, Becker T, Heckl SM, Lüschen S, Röcken C.   +6 more
europepmc   +1 more source

Real-world outcome of neoadjuvant therapy with or without pembrolizumab for triple-negative breast cancer. [PDF]

Acta Oncol
Maunu M, Lähteenmaa J, Karihtala P, Tuohinen S, Laaksolilja J, Laaksolilja J, Ståhls A, Meretoja T, Mattson J.   +8 more
europepmc   +1 more source